Table 1.
Variables | Group 1 (n = 40) | Group 2 (n = 69) | Group 3 (n = 122) | p |
---|---|---|---|---|
Age (years) (mean, range) |
63 31–78 |
60 23–83 |
65 42–91 |
0.15 |
Male sex (number, %) | 36, 90.0% | 48, 69.6% | 114, 93.4% | < 0.01* |
Treatment for primary site | 0.11 | |||
Surgery (number, %) | 26, 65.0% | 60, 87.0% | 110, 83.8% | |
Chemotherapy | 8, 20.0% | 4, 5.8% | 12, 9.8% | |
Radiotherapy or ablation | 1, 2.5% | 1, 1.4% | 2, 1.6% | |
Unknown | 5, 12.5% | 4, 5.8% | 7, 5.8% | |
Disease-free interval (month) | 33.6 ± 28.8 | 20.5 ± 14.7 | 27.1 ± 20.2 | 0.02* |
Pathological maximum diameter (mm) | 24.2 ± 28.9 | 30.8 ± 37.3 | 27.8 ± 24.3 | 0.09 |
Procedures (number, percent) | 0.21 | |||
Sublobar | 28, 70.0% | 41, 59.4% | 64, 52.5% | |
Lobectomy or more | 12, 30.0% | 28, 40.6% | 58, 47.5% |
Note: *p < 0.05 indicates significant values.